Hear from Dr. Brian Slomovitz as he provides a debrief on the ESMO Congress 2023 LBA innovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer. Recorded on October 27, 2023Duration approximately 30 minutes Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.
If you have questions or need assistance, contact education@igcs.org.
Brian Slomovitz, MDDirector of Gynecologic OncologicCo-Chair of the Cancer Research CommitteeMount Sinai Medical CenterUterine Cancer Lead for GOG PartnerUSA
A specialist in clinical trial development, robotic surgery, sentinel lymph node evaluation, and immunotherapy, Dr. Brian Slomovitz is Director of gynecologic oncologic and Co-Chair of the Cancer Research Committee at Mount Sinai Medical Center in Miami Beach, Florida. He is also a Professor of Obstetrics and Gynecology at Florida International University. Dr. Slomovitz is a member of the Board of Directors at the GOG Foundation and the Uterine Cancer Lead for GOG Partners. He is also the national or global principal investigator on a number of GOG Partners, NCI, and Alliance Foundation clinical trials. He authored more than 100 peer-reviewed articles and lectured extensively. In addition, Dr. Slomovitz has been recognized as a Top Doctor by Castle Connolly Medical for the past several years. Dr. Slomovitz graduated from Rutgers University – New Jersey Medical School, and completed his residency at New York Presbyterian – Cornell Medical Center in 2002. At MD Anderson Cancer Center, he completed a fellowship in gynecologic oncology in 2006. He is board certified in both obstetrics and gynecology and gynecologic oncology.
Floor Backes, MDModeratorDirector of Clincial Research and Fellowship Director for the Division of Gynecologic OncologyThe Ohio State University Wexner Medical CenterJames Comprehensive Cancer CenterUSA